Rifkin Jason Andrew 4
4 · DELCATH SYSTEMS INC · Filed Oct 14, 2009
Insider Transaction Report
Form 4
Rifkin Jason Andrew
Sr. VP Clinical Oper. & Secy
Transactions
- Award
Stock Option (right to buy)
2009-10-12+75,000→ 75,000 totalExercise: $5.46Exp: 2019-10-12→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The option vests 33% on October 12, 2010, 33% on October 12, 2011, and 34% on October 12, 2012.